Interpreting the APERITIF Randomized Clinical Trial—Reply

Дата публикации: 01-08-2026 00:00:00

In Reply Chen and Xiong raise important points. Given the open-label design of the trial, the selection of antiplatelet therapy was not random. As suggested, we analyzed the prevalence of left ventricular (LV) thrombus, maximal thrombus diameter, and Bleeding Academic Research Consortium (BARC) type 1 bleeding at 1 month according to the antithrombotic regimen at hospital discharge (Table). Discontinuation of antithrombotic therapy is reported in Supplement 3.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Interpreting the APERITIF Randomized Clinical Trial	0	13.07	01-08-2026
2	Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk	0	7.22	01-08-2026
3	Prasugrel—The Default P2Y12 Inhibitor After PCI for ACS?	0	7.98	01-08-2026
4	The impact of smoking status on clopidogrel responsiveness in patients with coronary artery disease who undergo percutaneous coronary intervention. [version 3; peer review: 1 approved, 1 not approved]	0	5.86	27-07-2026
5	Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke	0	7	13-07-2026
6	Unanswered Questions in Aldosteronism and Cardiovascular Risk	0	5.33	01-08-2026
7	Hemostatic Profiling of Generic Factor Xa Inhibitors Using ROTEM® Viscoelastometry and Multimodal Coagulation Assays: A Real-World Study in a Tunisian Cohort [version 1; peer review: awaiting peer review]	0	9.38	17-07-2026
8	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
9	Catheter-Based LAAC vs OAC in Patients With AF	0	13.15	26-08-2026
10	More than a million adults taking statins might not need them, study suggests - but experts urge caution	0	8.4	12-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.38. Источник: archderm.jamanetwork.com.